Patent US4382955A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4382955A Expired / Lapsed US ⏱️ 0.0 years remaining

Derivative of 4-(N-(3,4-dihydroxybenzylidene) aminomethyl cyclohexane-1-carboxylic acid

Assignee: Kureha Corp
•
Filing: 1981-05-26
•
Granted: 1983-05-10
•
Expires: 2001-05-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel compound of 4-[N-(3',4'-dihydroxybenzylidene) aminomethyl]cyclohexane-1-carboxylic acid or a salt or an ester thereof which has specific pharmacologic activities, a method for preparing thereof and a pharmaceutical composition comprising thereof as an active ingredient are provided.

Inventors

  • 👤 Hitoshi Takita
  • 👤 Yutaka Mukaida
  • 👤 Sakuo Noda
  • 👤 Hidetoshi Kobayashi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 10:29
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19; A61K31/195

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 12 words
A compound of 4-[N-(3',4'-dihydroxybenzylidene)aminomethyl]cyclohexane-1-carboxylic acid or a salt or an ester thereof.
Claim 2
Dependent Claim 12 words
A compound of 4-[N-(3',4'-dihydroxybenzylidene)aminomethyl]cyclohexane-1-carboxylic acid or a salt or an ester thereof.
Claim 3
Dependent Claim 9 words
The compound of claim 1, which is trans-4-[N-(3',4'-dihydroxybenzylidene)aminomethyl]cyclohexane-1-carboxylic acid.
Claim 4
Dependent Claim 9 words
The compound of claim 1, which is sodium trans-4-[N'-(3',4'-dihydroxybenzylidene)aminomethyl]cyclohexane-1-carboxylate.
Claim 5
Dependent Claim 9 words
The compound of claim 1, which is ethyl trans-4-[N-(3',4'-dihydroxybenzylidene)aminomethyl]cyclohexane-1-carboxylate.
Claim 6
Dependent Claim 9 words
The compound of claim 1, which is cis-4-[N-(3',4'-dihydroxybenzylidene)aminomethyl]cyclohexane-1-carboxylic acid.
Claim 7
Dependent Claim 43 words
A pharmaceutical composition in dosage unit form, having an inhibitory function on platelet aggregation and polynuclear leukocyte migration, comprising an effective amount of 4-N-(3',4'-dihydroxybenzylidene)aminomethyl cyclohexane-1-carboxylic acid or esters thereof or a pharmaceutical acceptable salt thereof, and a pharmaceutical carrier or a diluent therefor.
Claim 8
Dependent Claim 43 words
A pharmaceutical composition in dosage unit form, having an inhibitory function on platelet aggregation and polynuclear leukocyte migration, comprising an effective amount of 4-N-(3',4'-dihydroxybenzylidene)aminomethyl cyclohexane-1-carboxylic acid or esters thereof or a pharmaceutical acceptable salt thereof, and a pharmaceutical carrier or a diluent therefor.

References Cited (Backward Citations)

SU174617A1 Cited
US2577900A Cited
US3697589A Cited
US4198349A Cited
JPS55145652A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-05-09 1986-11-08 1987-05-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-05-09 1990-11-08 1991-05-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-05-09 1994-11-08 1995-05-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag